Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.10.23 | OSE Immunotherapeutics - Anticipation builds with positive OSE-279 data | 267 | Edison Investment Research | At the AACR-NCI-EORTC conference in Boston, OSE presented the initial positive data supporting the potential efficacy of its anti-PD1 monoclonal antibody, OSE-279, in patients with advanced solid tumours... ► Artikel lesen | |
17.10.23 | Paradigm Biopharma - Durable responses observed for kOA | 265 | Edison Investment Research | Paradigm has announced positive day-365 data from its Phase II trial (PARA_OA_008) assessing injectable pentosan polysulfate (iPPS) as a potentially disease-modifying treatment for knee osteoarthritis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 329 |
EVOTEC | 295 |
TUI | 210 |
NVIDIA | 179 |
DEUTSCHE BANK | 172 |
BAYER | 158 |
PLUG POWER | 145 |
NEL | 135 |
RHEINMETALL | 133 |
SIEMENS ENERGY | 112 |
BARRICK GOLD | 111 |
COMMERZBANK | 107 |
BASF | 104 |
TESLA | 104 |
RWE | 93 |
VOLKSWAGEN | 93 |
BYD | 87 |
ALLIANZ | 85 |
DEUTSCHE LUFTHANSA | 85 |
MERCEDES-BENZ | 79 |
RENK GROUP | 79 |
DEUTSCHE TELEKOM | 76 |
HEIDELBERGER DRUCK | 76 |
ALIBABA | 72 |
AIXTRON SE | 71 |